Publication:
Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia.

cris.virtualsource.author-orcid1e763b97-c5dd-498f-a07c-4d12cf80b661
datacite.rightsopen.access
dc.contributor.authorBoettiger, D C
dc.contributor.authorLaw, M G
dc.contributor.authorRoss, J
dc.contributor.authorHuy, B V
dc.contributor.authorHeng, Bsl
dc.contributor.authorDitangco, R
dc.contributor.authorKiertiburanakul, S
dc.contributor.authorAvihingsanon, A
dc.contributor.authorCuong, D D
dc.contributor.authorKumarasamy, N
dc.contributor.authorKamarulzaman, A
dc.contributor.authorLy, P S
dc.contributor.authorYunihastuti, E
dc.contributor.authorParwati Merati, T
dc.contributor.authorZhang, F
dc.contributor.authorKhusuwan, S
dc.contributor.authorChaiwarith, R
dc.contributor.authorLee, M P
dc.contributor.authorSangle, S
dc.contributor.authorChoi, J Y
dc.contributor.authorKu, W W
dc.contributor.authorTanuma, J
dc.contributor.authorNg, O T
dc.contributor.authorSohn, A H
dc.contributor.authorWester, C W
dc.contributor.authorNash, D
dc.contributor.authorMugglin, Catrina Andrea
dc.contributor.authorPujari, S
dc.date.accessioned2024-09-02T15:43:58Z
dc.date.available2024-09-02T15:43:58Z
dc.date.issued2020-02-20
dc.description.abstractObjectives Integration of HIV and non-communicable disease services improves the quality and efficiency of care in low- and middle-income countries (LMICs). We aimed to describe current practices for the screening and management of atherosclerotic cardiovascular disease (ASCVD) among adult HIV clinics in Asia. Methods Sixteen LMIC sites included in the International Epidemiology Databases to Evaluate AIDS - Asia-Pacific network were surveyed. Results Sites were mostly (81%) based in urban public referral hospitals. Half had protocols to assess tobacco and alcohol use. Protocols for assessing physical inactivity and obesity were in place at 31% and 38% of sites, respectively. Most sites provided educational material on ASCVD risk factors (between 56% and 75% depending on risk factors). A total of 94% reported performing routine screening for hypertension, 100% for hyperlipidaemia and 88% for diabetes. Routine ASCVD risk assessment was reported by 94% of sites. Protocols for the management of hypertension, hyperlipidaemia, diabetes, high ASCVD risk and chronic ischaemic stroke were in place at 50%, 69%, 56%, 19% and 38% of sites, respectively. Blood pressure monitoring was free for patients at 69% of sites; however, most required patients to pay some or all the costs for other ASCVD-related procedures. Medications available in the clinic or within the same facility included angiotensin-converting enzyme inhibitors (81%), statins (94%) and sulphonylureas (94%). Conclusion The consistent availability of clinical screening, diagnostic testing and procedures and the availability of ASCVD medications in the Asian LMIC clinics surveyed are strengths that should be leveraged to improve the implementation of cardiovascular care protocols.
dc.description.numberOfPages8
dc.description.sponsorshipInstitut für Sozial- und Präventivmedizin (ISPM)
dc.identifier.doi10.7892/boris.142346
dc.identifier.pmid32175086
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/35121
dc.language.isoen
dc.publisherMediscript
dc.relation.ispartofJournal of virus eradication
dc.relation.issn2055-6640
dc.relation.organizationDCD5A442BECFE17DE0405C82790C4DE2
dc.subjectAsia HIV atherosclerosis cardiovascular disease hypertension
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.subject.ddc300 - Social sciences, sociology & anthropology::360 - Social problems & social services
dc.titleAtherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia.
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage18
oaire.citation.issue1
oaire.citation.startPage11
oaire.citation.volume6
oairecerif.author.affiliationInstitut für Sozial- und Präventivmedizin (ISPM)
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2020-04-07 15:01:52
unibe.description.ispublishedpub
unibe.eprints.legacyId142346
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
Boettiger JVirusErad 2020 .pdf
Size:
222.21 KB
Format:
Adobe Portable Document Format
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections